{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:47:04Z","timestamp":1791308824483,"version":"4.3.1"},"reference-count":91,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Endocrinology & Metabolism"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.tem.2009.05.006","type":"journal-article","created":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T14:35:29Z","timestamp":1254407729000},"page":"444-451","source":"Crossref","is-referenced-by-count":78,"title":["Mineralocorticoid receptors in the metabolic syndrome"],"prefix":"10.1016","volume":"20","author":[{"given":"Maria-Christina","family":"Zennaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Caprio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"F\u00e8ve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tem.2009.05.006_bib1","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.tem.2008.01.004","article-title":"Adipose cell-adrenal interactions: current knowledge and future perspectives","volume":"19","author":"Ronconi","year":"2008","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.tem.2009.05.006_bib2","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1096\/fj.06-7970com","article-title":"Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis","volume":"21","author":"Caprio","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.tem.2009.05.006_bib3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0083-6729(03)01002-1","article-title":"Aldosterone: its receptor, target genes, and actions","volume":"66","author":"Pearce","year":"2003","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.tem.2009.05.006_bib4","doi-asserted-by":"crossref","first-page":"e012","DOI":"10.1621\/nrs.05012","article-title":"The mineralocorticoid receptor: insights into its molecular and (patho)physiological biology","volume":"5","author":"Viengchareun","year":"2007","journal-title":"Nucl. Recept. Signal"},{"key":"10.1016\/j.tem.2009.05.006_bib5","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1046\/j.1523-1755.2000.00962.x","article-title":"Pleiotropic action of aldosterone in epithelia mediated by transcription and post-transcription mechanisms","volume":"57","author":"Verrey","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.tem.2009.05.006_bib6","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/humu.20371","article-title":"Mineralocorticoid receptor mutations are the principal cause of renal type 1 pseudohypoaldosteronism","volume":"28","author":"Pujo","year":"2007","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.tem.2009.05.006_bib7","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0092-8674(01)00241-0","article-title":"Molecular mechanisms of human hypertension","volume":"104","author":"Lifton","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.tem.2009.05.006_bib8","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1126\/science.3037703","article-title":"Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor","volume":"237","author":"Arriza","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.tem.2009.05.006_bib9","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1210\/endo-92-4-994","article-title":"The roles of plasma binding and receptor specificity in the mineralocorticoid action of aldosterone","volume":"92","author":"Funder","year":"1973","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2009.05.006_bib10","doi-asserted-by":"crossref","first-page":"F181","DOI":"10.1152\/ajprenal.2001.280.2.F181","article-title":"Multiple aspects of mineralocorticoid selectivity","volume":"280","author":"Farman","year":"2001","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"10.1016\/j.tem.2009.05.006_bib11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10741-005-2344-2","article-title":"Mineralocorticoid receptors: distribution and activation","volume":"10","author":"Funder","year":"2005","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.tem.2009.05.006_bib12","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1210\/er.2008-0024","article-title":"The metabolic syndrome","volume":"29","author":"Cornier","year":"2008","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.tem.2009.05.006_bib13","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1161\/ATVBAHA.107.147835","article-title":"Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis","volume":"27","author":"Gustafson","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"Suppl 2","key":"10.1016\/j.tem.2009.05.006_bib14","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1038\/ijo.2008.30","article-title":"Cardiometabolic risk: a Framingham perspective","volume":"32","author":"Wilson","year":"2008","journal-title":"Int. J. Obes. (Lond.)"},{"key":"10.1016\/j.tem.2009.05.006_bib15","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.beem.2005.07.007","article-title":"Adipogenesis: cellular and molecular aspects","volume":"19","author":"Feve","year":"2005","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2009.05.006_bib16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.diabet.2007.09.004","article-title":"Adipokines: the missing link between insulin resistance and obesity","volume":"34","author":"Antuna-Puente","year":"2008","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.tem.2009.05.006_bib17","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1210\/jc.2006-1055","article-title":"Relationship between adipocyte size and adipokine expression and secretion","volume":"92","author":"Skurk","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2009.05.006_bib18","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1172\/JCI200319246","article-title":"Obesity is associated with macrophage accumulation in adipose tissue","volume":"112","author":"Weisberg","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2009.05.006_bib19","first-page":"4","article-title":"Recent advances in the relationship between obesity, inflammation, and insulin resistance","volume":"17","author":"Bastard","year":"2006","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.tem.2009.05.006_bib20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S1043-2760(01)00517-3","article-title":"Adipogenesis: forces that tip the scales","volume":"13","author":"MacDougald","year":"2002","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.tem.2009.05.006_bib21","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1046\/j.1365-2796.1999.00490.x","article-title":"The role of TNFalpha and TNF receptors in obesity and insulin resistance","volume":"245","author":"Hotamisligil","year":"1999","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.tem.2009.05.006_bib22","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.tem.2008.01.006","article-title":"Primary aldosteronism: cardiovascular, renal and metabolic implications","volume":"19","author":"Rossi","year":"2008","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.tem.2009.05.006_bib23","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1161\/HYPERTENSIONAHA.107.103267","article-title":"Selective mineralocorticoid receptor blocker eplerenone reduces resistance artery stiffness in hypertensive patients","volume":"51","author":"Savoia","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2009.05.006_bib24","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1161\/01.HYP.0000231338.41548.fc","article-title":"Plasma aldosterone is independently associated with the metabolic syndrome","volume":"48","author":"Bochud","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2009.05.006_bib25","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/01.HYP.0000253258.36141.c7","article-title":"Association of adrenal steroids with hypertension and the metabolic syndrome in blacks","volume":"49","author":"Kidambi","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2009.05.006_bib26","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1161\/CIRCULATIONAHA.107.708537","article-title":"Multimarker approach to evaluate the incidence of the metabolic syndrome and longitudinal changes in metabolic risk factors: the Framingham Offspring Study","volume":"116","author":"Ingelsson","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.tem.2009.05.006_bib27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa033263","article-title":"Serum aldosterone and the incidence of hypertension in nonhypertensive persons","volume":"351","author":"Vasan","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2009.05.006_bib28","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1210\/jc.2005-1733","article-title":"Prevalence and characteristics of the metabolic syndrome in primary aldosteronism","volume":"91","author":"Fallo","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2009.05.006_bib29","doi-asserted-by":"crossref","first-page":"13219","DOI":"10.1073\/pnas.221467098","article-title":"Genetic variation in aldosterone synthase predicts plasma glucose levels","volume":"98","author":"Ranade","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tem.2009.05.006_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/joe.1.06017","article-title":"The new biology of aldosterone","volume":"186","author":"Connell","year":"2005","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.tem.2009.05.006_bib31","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1042\/CS20060275","article-title":"Mineralocorticoid receptor activation and cardiac fibrosis","volume":"112","author":"Young","year":"2007","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.tem.2009.05.006_bib32","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1681\/ASN.2006080944","article-title":"Enhanced aldosterone signaling in the early nephropathy of rats with metabolic syndrome: possible contribution of fat-derived factors","volume":"17","author":"Nagase","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.tem.2009.05.006_bib33","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1161\/HYPERTENSIONAHA.107.091058","article-title":"Salt-induced nephropathy in obese spontaneously hypertensive rats via paradoxical activation of the mineralocorticoid receptor: role of oxidative stress","volume":"50","author":"Nagase","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2009.05.006_bib34","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/nm.1879","article-title":"Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease","volume":"14","author":"Shibata","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.tem.2009.05.006_bib35","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1056\/NEJM200109203451215","article-title":"Spironolactone in addition to ACE inhibition to reduce proteinuria in patients with chronic renal disease","volume":"345","author":"Chrysostomou","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2009.05.006_bib36","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10741-005-2352-2","article-title":"The role of aldosterone blockade in patients with heart failure","volume":"10","author":"Pitt","year":"2005","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.tem.2009.05.006_bib37","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1530\/eje.0.1510305","article-title":"Would wider screening for primary aldosteronism give any health benefits? Eur","volume":"151","author":"Plouin","year":"2004","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.tem.2009.05.006_bib38","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1161\/01.CIR.95.6.1471","article-title":"Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma","volume":"95","author":"Rossi","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.tem.2009.05.006_bib39","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.tem.2009.05.006_bib40","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1210\/jc.2005-0681","article-title":"Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I","volume":"90","author":"Stowasser","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2009.05.006_bib41","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1042\/cs1030425","article-title":"Aldosterone induces acute endothelial dysfunction in vivo in humans: evidence for an aldosterone-induced vasculopathy","volume":"103","author":"Farquharson","year":"2002","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.tem.2009.05.006_bib42","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/01.CIR.101.6.594","article-title":"Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I\/angiotensin II conversion in patients with chronic heart failure","volume":"101","author":"Farquharson","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.tem.2009.05.006_bib43","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nm1545","article-title":"Aldosterone impairs vascular reactivity by decreasing glucose\u20136-phosphate dehydrogenase activity","volume":"13","author":"Leopold","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.tem.2009.05.006_bib44","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1161\/CIRCRESAHA.108.174235","article-title":"Functional mineralocorticoid receptors in human vascular endothelial cells regulate intercellular adhesion molecule-1 expression and promote leukocyte adhesion","volume":"102","author":"Caprio","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.tem.2009.05.006_bib45","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0091-7435(87)90087-9","article-title":"Incidence and precursors of hypertension in young adults: the Framingham Offspring Study","volume":"16","author":"Garrison","year":"1987","journal-title":"Prev. Med."},{"key":"10.1016\/j.tem.2009.05.006_bib46","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/01.mnh.0000214775.42103.a5","article-title":"From big fat cells to high blood pressure: a pathway to obesity-associated hypertension","volume":"15","author":"Pausova","year":"2006","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.tem.2009.05.006_bib47","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nature05488","article-title":"Abdominal obesity and metabolic syndrome","volume":"444","author":"Despres","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.tem.2009.05.006_bib48","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/sj.jhh.1000391","article-title":"ACE, angiotensinogen and obesity: a potential pathway leading to hypertension","volume":"11","author":"Cooper","year":"1997","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.tem.2009.05.006_bib49","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/j.1550-8528.1999.tb00418.x","article-title":"Visceral obesity and insulin resistance are associated with plasma aldosterone levels in women","volume":"7","author":"Goodfriend","year":"1999","journal-title":"Obes. Res."},{"key":"10.1016\/j.tem.2009.05.006_bib50","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1172\/JCI17845","article-title":"Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice","volume":"112","author":"Masuzaki","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2009.05.006_bib51","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0091-3057(85)90517-9","article-title":"Continuous infusion of aldosterone: correlates of body weight gain","volume":"22","author":"Devenport","year":"1985","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.tem.2009.05.006_bib52","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1172\/JCI114345","article-title":"Promoting effects of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium","volume":"84","author":"Hauner","year":"1989","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2009.05.006_bib53","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1210\/en.132.6.2421","article-title":"Aldosterone stimulates differentiation of mouse 3T3-L1 cells into adipocytes","volume":"132","author":"Rondinone","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2009.05.006_bib54","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1210\/me.2004-0539","article-title":"A Nuclear Receptor Atlas: 3T3-L1 adipogenesis","volume":"19","author":"Fu","year":"2005","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.tem.2009.05.006_bib55","doi-asserted-by":"crossref","first-page":"E386","DOI":"10.1152\/ajpendo.2000.279.2.E386","article-title":"The mineralocorticoid receptor mediates aldosterone-induced differentiation of T37i cells into brown adipocytes","volume":"279","author":"Penfornis","year":"2000","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2009.05.006_bib56","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1172\/JCI1915","article-title":"Hibernoma development in transgenic mice identifies brown adipose tissue as a novel target of aldosterone action","volume":"101","author":"Zennaro","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2009.05.006_bib57","doi-asserted-by":"crossref","first-page":"E640","DOI":"10.1152\/ajpendo.2001.280.4.E640","article-title":"Mineralocorticoid and glucocorticoid receptors inhibit UCP expression and function in brown adipocytes","volume":"280","author":"Viengchareun","year":"2001","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2009.05.006_bib58","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/366740a0","article-title":"Development of obesity in transgenic mice after genetic ablation of brown adipose tissue","volume":"366","author":"Lowell","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.tem.2009.05.006_bib59","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1073\/pnas.0610416104","article-title":"Ectopic brown adipose tissue in muscle provides a mechanism for differences in risk of metabolic syndrome in mice","volume":"104","author":"Almind","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tem.2009.05.006_bib60","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1056\/NEJMoa0808718","article-title":"Cold-activated brown adipose tissue in healthy men","volume":"360","author":"van Marken Lichtenbelt","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2009.05.006_bib61","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1056\/NEJMoa0808949","article-title":"Functional brown adipose tissue in healthy adults","volume":"360","author":"Virtanen","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2009.05.006_bib62","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa0810780","article-title":"Identification and importance of brown adipose tissue in adult humans","volume":"360","author":"Cypess","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2009.05.006_bib63","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1152\/physrev.1998.78.3.783","article-title":"Understanding adipocyte differentiation","volume":"78","author":"Gregoire","year":"1998","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.tem.2009.05.006_bib64","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1126\/science.1066285","article-title":"A transgenic model of visceral obesity and the metabolic syndrome","volume":"294","author":"Masuzaki","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.tem.2009.05.006_bib65","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0140-6736(06)68699-6","article-title":"Cushing's syndrome","volume":"367","author":"Newell-Price","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.tem.2009.05.006_bib66","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2337\/diabetes.53.4.931","article-title":"Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice","volume":"53","author":"Morton","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2009.05.006_bib67","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.2337\/diabetes.54.4.1023","article-title":"Adipocyte-specific glucocorticoid inactivation protects against diet-induced obesity","volume":"54","author":"Kershaw","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2009.05.006_bib68","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.cell.2006.06.050","article-title":"Nuclear receptor expression links the circadian clock to metabolism","volume":"126","author":"Yang","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.tem.2009.05.006_bib69","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1677\/JME-08-0144","article-title":"Corticosteroid receptors, macrophages and cardiovascular disease","volume":"42","author":"Rickard","year":"2009","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.tem.2009.05.006_bib70","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1161\/01.HYP.0000248135.97380.76","article-title":"Angiotensin II induces interleukin-6 in humans through a mineralocorticoid receptor-dependent mechanism","volume":"48","author":"Luther","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2009.05.006_bib71","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1210\/jc.87.2.448","article-title":"Spironolactone abolishes the relationship between aldosterone and plasminogen activator inhibitor-1 in humans","volume":"87","author":"Sawathiparnich","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2009.05.006_bib72","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1210\/en.2006-0944","article-title":"Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus","volume":"147","author":"Guo","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2009.05.006_bib73","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1210\/jc.2007-0393","article-title":"Beneficial effects of eplerenone versus hydrochlorothiazide on coronary circulatory function in patients with diabetes mellitus","volume":"92","author":"Joffe","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2009.05.006_bib74","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.metabol.2006.07.025","article-title":"The effect of spironolactone on circulating adipocytokines in patients with type 2 diabetes mellitus complicated by diabetic nephropathy","volume":"55","author":"Matsumoto","year":"2006","journal-title":"Metabolism"},{"key":"10.1016\/j.tem.2009.05.006_bib75","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1210\/jc.2005-1718","article-title":"Aldosterone blockade attenuates urinary monocyte chemoattractant protein-1 and oxidative stress in patients with type 2 diabetes complicated by diabetic nephropathy","volume":"91","author":"Takebayashi","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2009.05.006_bib76","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1038\/sj.ki.5001854","article-title":"Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease","volume":"70","author":"Bianchi","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.tem.2009.05.006_bib77","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1161\/CIRCULATIONAHA.107.748640","article-title":"Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines","volume":"117","author":"Guo","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.tem.2009.05.006_bib78","doi-asserted-by":"crossref","first-page":"E110","DOI":"10.1152\/ajpendo.00258.2007","article-title":"Low-dose spironolactone reduces reactive oxygen species generation and improves insulin-stimulated glucose transport in skeletal muscle in the TG(mRen2)27 rat","volume":"295","author":"Lastra","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2009.05.006_bib79","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.bbrc.2006.02.065","article-title":"Mineralocorticoid receptor is involved in the regulation of genes responsible for hepatic glucose production","volume":"342","author":"Liu","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tem.2009.05.006_bib80","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1161\/HYPERTENSIONAHA.107.093955","article-title":"Aldosterone suppresses insulin signaling via the downregulation of insulin receptor substrate-1 in vascular smooth muscle cells","volume":"50","author":"Hitomi","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2009.05.006_bib81","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0960-0760(03)00072-4","article-title":"Transcriptional inhibition of the human insulin receptor gene by aldosterone","volume":"84","author":"Calle","year":"2003","journal-title":"J. Steroid. Biochem. Mol. Biol."},{"key":"10.1016\/j.tem.2009.05.006_bib82","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1046\/j.1467-789x.2001.00027.x","article-title":"Do stress reactions cause abdominal obesity and comorbidities?","volume":"2","author":"Bjorntorp","year":"2001","journal-title":"Obes. Rev."},{"key":"10.1016\/j.tem.2009.05.006_bib83","doi-asserted-by":"crossref","first-page":"5083","DOI":"10.1210\/jc.2006-0915","article-title":"A common polymorphism in the mineralocorticoid receptor modulates stress responsiveness","volume":"91","author":"DeRijk","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2009.05.006_bib84","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0002-9610(64)90252-1","article-title":"Clinical Characteristics Of Primary Aldosteronism From An Analysis Of 145 Cases","volume":"107","author":"Conn","year":"1964","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.tem.2009.05.006_bib85","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1097\/HJH.0b013e3282861fa4","article-title":"A possible association between primary aldosteronism and a lower beta-cell function","volume":"25","author":"Mosso","year":"2007","journal-title":"J. Hypertens."},{"key":"10.1016\/j.tem.2009.05.006_bib86","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.amjhyper.2007.03.012","article-title":"Adiponectin and insulin sensitivity in primary aldosteronism","volume":"20","author":"Fallo","year":"2007","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.tem.2009.05.006_bib87","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1161\/HYPERTENSIONAHA.108.122002","article-title":"Fasting plasma glucose and serum lipids in patients with primary aldosteronism: a controlled cross-sectional study","volume":"53","author":"Matrozova","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2009.05.006_bib88","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/sj.jhh.1001292","article-title":"Serum leptin levels in patients with primary hyperaldosteronism before and after treatment: relationships to insulin sensitivity","volume":"16","author":"Haluzik","year":"2002","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.tem.2009.05.006_bib89","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/HJH.0b013e3280108e6f","article-title":"Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study","volume":"25","author":"Giacchetti","year":"2007","journal-title":"J. Hypertens."},{"key":"10.1016\/j.tem.2009.05.006_bib90","doi-asserted-by":"crossref","first-page":"503","DOI":"10.33549\/physiolres.930298","article-title":"Does the treatment of primary hyperaldosteronism influence glucose tolerance?","volume":"52","author":"Strauch","year":"2003","journal-title":"Physiol. Res."},{"key":"10.1016\/j.tem.2009.05.006_bib91","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1210\/jc.2006-0736","article-title":"Insulin sensitivity in patients with primary aldosteronism: a follow-up study","volume":"91","author":"Catena","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Trends in Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276009001088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276009001088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T21:57:00Z","timestamp":1710626220000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043276009001088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":91,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S1043276009001088"],"URL":"https:\/\/doi.org\/10.1016\/j.tem.2009.05.006","relation":{},"ISSN":["1043-2760"],"issn-type":[{"value":"1043-2760","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}